Recent studies using chemiluminescence and spectrophotometry have shown that cultured and native endothelial cells release nitric oxide (NO). Pharmacological and biochemical evidence argue for and against the proposal that endothelium-derived relaxing factor (EDRF) is identical with free NO. In an attempt to identify EDRF as free NO, a bioassay technique was combined with an NO trap (hemoglobin bound to agarose; Ag-Hb), and electron paramagnetic resonance (EPR) spectroscopy was used to detect the resultant nitrosylhemoglobin (NO-Hb). Canine femoral arteries with or without endothelium were perfused with physiological saline solution containing superoxide dismutase and ibuprofen and were stimulated with acetylcholine. The relaxing activity of the effluent was monitored in canine coronary artery rings without endothelium (bioassay tissue) half-maximally contracted with U46619. Acetylcholine stimulated the release of EDRF from intact femoral arteries (but not from segments without endothelium), which relaxed the bioassay tissue by 63+±5%. NO (-1 and -10 nM) infused directly over the bioassay tissue produced 34±8% and 96±3% relaxation, respectively (ED%, --2 nM). Effluents were collected under vacuum in the absence of oxygen through a column containing Ag-Hb, and the samples were assayed for NO-Hb by EPR. Samples containing NO produced the triplet EPR signal characteristic of NO-Hb, but the effluent containing EDRF did not. Infusion of NO through the donor tissue in the presence of acetylcholine gave an EPR signal similar to that observed when NO had no contact with the tissue. Nitrite anion (up to 2.7X 102 M) produced no detectable NO-Hb in analogous experiments. Thus, EDRF released from the native endothelium of canine femoral artery cannot be identified as free NO. The present findings support a concept that EDRF may be a labile precursor of NO. (Circulation Research 1990;67:1446-1452 E ndothelium-derived relaxing factor (EDRF) is a potent vasodilator substance released by the endothelium.1-3 Recently, it has been proposed that EDRF may be identical with nitric oxide (NO).4-6 Both pharmacological and biochemical evidence support this proposal.4-11 NO and EDRF both are inactivated by superoxide anion and hemoglobin and are protected by superoxide dismutase.4-9 The biological half-life of EDRF and NO is similar.4-9 Finally, the release of EDRF by bradykiFrom the
relaxation is not.18 NO cannot account for the vascular relaxation produced by endothelium-dependent vasorelaxants in canine veins. 19 In addition, neither the spectrophotometric method nor the chemiluminescence method (using an acidic reducing reflux chamber) for detection of NO can distinguish it from nitrite or labile nitroso species; although the former method actually determines the concentration of NO2 derived from oxidation of NO, use of a reducing acidic refluxing chamber with the chemiluminescence method results in reduction of NO2 and nitroso compounds to NO and elimination of the high specificity for NO. Thus, neither method can determine whether the initial EDRF was NO2 or a labile nitroso substance converted to NO or whether EDRF itself was free NO. Finally, using a modified chemiluminescence technique (without reflux chamber) in which NO is directly measured in the effluent, Guerra and coworkers20,21 found that the concentration of NO generated by endothelial cells could not account for the relaxation observed in a bioassay preparation.
The neutral molecule NO is paramagnetic and detectable by electron paramagnetic resonance (EPR) spectroscopy. However, NO is quite reactive, especially with oxygen and radicals (including itself), spontaneously forming diamagnetic species. Thus, to detect and monitor NO by EPR, it is necessary to trap and stabilize it. Deoxyhemoglobin has been used as a trap for NO, and EPR has been used to quantify the resulting nitrosylhemoglobin (NO-Hb).22 NO forms a relatively stable complex with reduced heme iron [Fe(II)J, and the chemical and spectroscopic properties of NO-Hb formed by hemoglobin trapping of NO have been well studied.2223 NO-Hb is unstable to aerobic oxidation; however, one valency hybrid (a+2NO8+3) has a unique aerobic stability. 23 The single unpaired electron in NO-Hb is located in an orbital primarily centered on the Fe(II), as indicated by the G value (>2.00) and breadth of the signal (due to G anisotropy). A diagnostic feature of the NO-Hb EPR spectrum, however, is the characteristic threeline hyperfine pattern that is due to electron-nuclear hyperfine coupling to the NO nitrogen (a['4N]=16.5 Gs) and that originates primarily from the NO-asubunit in its low-affinity form.23 This triplet feature at 3,200-3,400 G is specific for NO-Hb and is not seen when hemoglobin binds nitrite-or nitrogencontaining compounds such as azide or hydroxylamine, unless they have been converted into NO first.22 Thus, EPR presents an opportunity for the unequivocal identification of EDRF(s) as free NO.
The purpose of the present study was to test whether EDRF released by acetylcholine from the endothelium of canine femoral artery can be identified as free NO by EPR.
Materials and Methods

Preparation of Nitric Oxide
Boiled deionized water and 1 M NaOH (scrub solution) were aerated with 100% argon for 30 minutes before the preparation of NO solution and were kept sealed until use. NO gas (1% in helium) was passed through a trap containing 1 M NaOH, and the gas then was passed through oxygen-free, argon-treated deionized water for 20 minutes. The ambient temperature and barometric pressure were recorded. Molar concentration has been estimated based on the assumption that the stock solution was saturated with NO at a final concentration of approximately 0.02 mM (determined by using the standard gas equation and the solubility constant of NO in water at barometric pressure and ambient temperature). Analysis of the NO content of the stock solution by spectrophotometric assay24 resulted in a concentration of 0.61 mM nitrite equivalent. This value indicates that large amounts of HNO2 (-0.59 mM) accumulated during bubbling of the gas through the water, probably as a result of some NO2 being present in the gas and reacting with NO to form HNO2.25 The concentrated solution of NO then was diluted 1:19 with argon-treated HEPES-buffered salt solution (pH 7.4) and stored in an airtight container. The solution was further diluted 1:9 with HEPESbuffered solution and infused into the stream of perfusate (2 ml/min) at a rate of 0.02 or 0.2 ml/min, reaching final concentrations in the perfusate of approximately 1 and 10 nM, respectively.
Preparation of Reduced Hemoglobin-Agarose
Hemoglobin bound to agarose (Ag-Hb) (lot 77F-9625, Sigma Chemical Co., St. Louis), 50% wt/vol contained in 100 ml 0.9% saline solution, was shaken in its original vial to completely mix the solid and liquid phases. The bottle then was opened and immediately aerated with 100% argon gas (40 ml/ min) for 30 minutes to remove the oxygen from the solution. The bottle was capped, the Ag-Hb allowed to settle, the saline decanted, and the bottle filled with argon gas. Fifty milliliters of 10 mM methylene blue then was added, and the solution was shaken for 20 minutes. Glass columns (10 cm A perfusion-superfusion bioassay method developed by Rubanyi et a126 was used for this study. Both ends of a 3-4-cm-long segment of canine femoral artery were fixed to stainless steel cannulas (1.5 mm i.d.) and mounted vertically in an organ chamber filled with 20 ml aerated control solution at 370 C.
The segment was perfused at constant flow (2 ml/ min) with a multichannel roller pump. Two donor tissues (one with and one without endothelium) were present in each muscle chamber. Control solution was pumped at the same rate through a stainless steel tube placed in the center of the muscle chamber. To measure the responses to intraluminally released EDRF(s), a ring of canine circumflex coronary artery (bioassay tissue) from which the endothelium had been removed was suspended directly below the organ chamber by means of two stainless steel stirrups passed through its lumen, with one connected to a stationary rod and the second to an FT-03C force transducer (Grass Instrument Co., Quincy, Mass.) for the isometric measurement of force development. The entire bioassay set was free to move below the organ chamber, allowing the bioassay ring to undergo direct superfusion through the stainless steel tube or to assay the effluent from the donor tissues (endothelial superfusion). The transit time between the distal end of the segments and the bioassay tissue was less than 2 seconds. Drugs were infused into the perfusate at a rate of 0.02-0.2 ml/min with multichannel infusion pumps (Harvard Apparatus, South Natick, Mass.) either upstream (site 1) or downstream (site 2) of the perfused donor segments.
Experimental Protocol
Sixty minutes after the start of perfusion, both the donor and bioassay tissue (superfused through the stainless steel tube) were perfused and superfused, respectively, with a concentration (30-100 nM) of U46619 (Upjohn Diagnostics, Kalamazoo, Mich.) producing half-maximal contraction of the coronary artery bioassay ring. When the contraction of the bioassay rings to U46619 reached a steady state, acetylcholine (10-6 M; Sigma) was infused directly over the bioassay tissue for 5 minutes or until equilibrium responses were obtained, to verify the absence of functional endothelium. This procedure was repeated with low (-1 nM) and high (-10 nM) NO concentrations. The bioassay tissue then was moved under the donor tissue, and the response to infusion of acetylcholine (10-6 M) through the endotheliumcompetent or endothelium-rubbed donors was tested.
In another set of experiments, NO was infused below (site 2) and through (site 1) the donor tissue, rather than through the stainless steel tube, to evaluate the possibility that effluent from donor tissues contained a substance that bound the NO in a form which prevented (depressed) its ability to relax the bioassay tissue or its reaction with the Ag-Hb column.
Collection of Effluent for Electron Paramagnetic
Resonance Analysis
After establishment of relaxation responses to NO and EDRF, the bioassay tissue was removed, and effluents from donor tissues or the stainless steel tube were collected under vacuum through a 2.5 -cm column of reduced Ag-Hb (see above). The Ag-Hb column was mounted in a glove bag filled with argon gas (100%), and argon gas also was blown around the junction of the donor outlet and the column. The transit time through the Ag-Hb column was approximately 60 seconds. Control effluent (physiological saline solution [PSS] containing ibuprofen, SOD, and acetylcholine) was collected through the stainless steel tube for 9 minutes (2 ml/min). Effluents from donor tissues (with or without endothelium) were collected after addition of acetylcholine (10-6 M) to the PSS perfusing the donor femoral arteries for 9 minutes (2 ml/min). Freshly prepared NO (-1 and -10 nM; see above) was infused through the stainless steel tube or through the donor femoral artery with endothelium, and effluents were collected for 9 minutes (2 ml/min). The samples were immediately wrapped in parafilm, gassed with argon, and stored at -70°C or immediately packed in dry ice and shipped to Dartmouth College, where they were assayed for NO-Hb with EPR spectroscopy.
Electron Paramagnetic Resonance Analysis of EDRF and Nitric Oide Samples
In an argon-filled glove bag, the frozen suspension of Ag-Hb was thawed, removed from the glass column, loaded into a suprasil quartz EPR tube, sealed with a rubber septum, and frozen in liquid nitrogen. EPR spectra were obtained at 77 K on a Bruker ESP-300 spectrometer (Bruker Instruments Inc., Billerica, Mass.) operating at 9.42 GHz, with 20 mW power, 100 kHz modulation frequency, 5.1 G modulation amplitude, and scan conditions (time constant, sweep width, sweep time) to give 1.9 G resolution; each spectrum was the result of signal averaging over five scans. Under these conditions, we were able to 
Calculations and Statistical Analysis
Relaxation responses of the bioassay tissue to acetylcholine (EDRF) and NO were expressed as a percent of the initial contractile force to U46619. The data were analyzed with analyses of variance corrected for repeated measures. Means were compared with Newman-Keuls test and Tukey's procedure for between-or among-group comparisons, respectively. A value ofpc0.05 was accepted for statistical significance of differences between and among means.
Results
Bioassay Studies
NO (-1 and -10 nM), infused through the stainless steel tube over the bioassay tissue, produced concentration-dependent relaxations (34+8% and 96+3%, respectively; n=5) (ED50; --2 nM) ( Figure   1 (Figure 1 ). Acetylcholine did not stimulate the release of relaxant substance(s) from femoral arteries without endothelium ( Figure 1) .
We tested the possibility that the perfusate passing through the donor artery contains substance(s) that may interact with NO and diminish its ability to relax the bioassay tissue or its detectability as free NO by EPR (see below). Infusion of NO (-1 nM) into the perfusate either upstream (site 1) or downstream (site 2) of the intact femoral artery relaxed the bioassay coronary artery ring (n =4) (Figure 2 ) similar to the relaxation observed when NO was infused into the PSS through the stainless steel tube (Figure 1 ).
Electron Paramagnetic Resonance Analysis of NO-Hb
Columns of Ag-Hb exposed to effluents containing low (-1 nM) and high (-10 nM) concentrations of NO exhibited EPR signals (n=5) with the characteristic triplet hyperfine pattern of NO-Hb (Figure 3) . However, in none of the five experiments was the EPR signal for nitrosylhemoglobin-agarose found in samples exposed to control effluent, or to effluent from intact or rubbed femoral arteries stimulated with acetylcholine ( Figure 3) . A strong signal at G=6 (not shown) and a weaker feature in the G=2 region are attributed to methemoglobin originally present in the Ag-Hb. Figure 4 shows representative EPR data of the effects of infusing NO (-10 nM) through the intact femoral artery (site 1) in the presence of acetylcholine (10-6 M) . The characteristic EPR spectrum of NO-Hb was detectable and not attenuated by the passage of NO through the intact femoral artery. In contrast, the acetylcholine-stimulated effluent (containing EDRF but no authentic NO) did not generate the signal characteristic for NO-Hb.
To test whether nitrite (NO2-), which is in equilibrium with NO under acidic aqueous conditions,25 could contribute to the NO-Hb spectrum, we evaluated whether N02-solutions contain detectable levels of NO with these experimental conditions. Perfusing Ag-Hb columns with PSS containing different concentrations of NO2-(2.7xlO-9 to 2.7x 10-2 M) resulted in Ag-Hb samples exhibiting no EPR signals specific for NO-Hb to the limits of detection (-0.1 nmol NO-Hb). 20 who used a modified chemiluminescence procedure to measure directly only free NO in the effluent of porcine carotid arteries stimulated by acetylcholine and bradykinin. The concentration of free NO in the effluent from stimulated blood vessels containing endothelium was insufficient to account for relaxation of the bioassay tissues, when compared with exogenous authentic NO. However, the conclusion of Guerra et a120 and Myers et a121 can be drawn only if the possibility can be excluded (which the present study did not allow) that nitrogen oxides (other than nitrite) were present in the NO solution that have vasorelaxing properties and could generate NO-Hb under the experimental conditions used.
An alternative explanation is that EDRF may be a labile precursor of NO, which is in equilibrium with small amounts of free NO (either released from the endothelium or spontaneously dissociated from the putative precursor) in the aqueous effluent solution20,21 or which is converted to free NO by the target tissues (e.g., vascular smooth muscle or platelets). Preliminary observations support this concept and suggest that EDRF may be an S-nitrosothiol (e.g., S-nitroso-L-cysteine).30 '31 Further studies are now required to search for 1) potential nitrogen oxides other than nitrite in the NO solution that can contribute to the NO-Hb signal, or (if this possibility can be ruled out) 2) the identification of the exact structure of EDRF (probably a labile precursor of NO).
